GaldermaDeliversRecord2025ResultsWithNetSalesof5.207BillionUSD,up17.7%atConstantCurrency1,andCoreEBITDA2of1.211billionUSD,Growing18.9%atConstantCurrency
===2026/3/5 16:11:22===
Year-on-year growth
FY 2024
FY 2025
Constant currency
Reported
Group total
4,410
5,207
17.7%
18.1 %
By product category
Injectable Aesthetics
2,299
2,572
11.5%
11.9%
Neuromodulators
1,285
=*=*=*=*=*=
当前为第26/55页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页